The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)

Introduction: Infections caused by carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa, including isolates producing acquired carbapenemases, constitute a prevalent health problem worldwide. The primary objective of this study was to determine the distribution...

Descripción completa

Detalles Bibliográficos
Autores: Gracia Ahufinger, Irene, López-González, Laura, Vasallo, Francisco, Galar, Alicia, Siller, María, Pitart, Cristina, Bloise, Iván, Torrecillas, Miriam, Gijón Cordero, Desirée, Viñado Pérez, Belen, Castillo-García, Javier, Campo, Rainer, Mulet, Xavier, Madueño-Alonso, Ana, Chamizo-López, Francisco Javier, Arrastia-Erviti, Matiane, Galán-Sánchez, Fátima, Fernández-Quejo, Melisa, Rodríguez-Díaz, Juan Carlos, Gutiérrez-Zufiaurre, María Nieves, Rodríguez-Maresca, Manuel Angel, Ortega-Lafont, María del Pilar, Yagüe Guirao, Genoveva, Chaves-Blanco, Lucía, Colomina-Rodríguez, Javier, Vidal-Acuña, María Reyes, Portillo, María Eugenia, Franco-Álvarez de Luna, Francisco, Centelles-Serrano, María José, Azcona-Gutiérrez, José Manuel, Delgado-Iribarren García Campero, Alberto, Rey-Cao, Sonia, Muñoz, Patricia, Calvo Montes, Jorge, Zboromyrska, Yuliya, Grandioso, David, Càmara Mas, Jordi, Cantón, Rafael, Larrosa-Escartín, Nieves, Díaz Regañón, Jazmín, Martínez-Martínez, Luis
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/225042
Acceso en línea:https://hdl.handle.net/2445/225042
Access Level:acceso abierto
Palabra clave:Bacteris gramnegatius
Escheríchia coli
Klebsiella pneumoniae
Gram-negative bacteria
Escherichia coli
id ES_b98d8f1ee69c4c0eb073d2f48e63bf2f
oai_identifier_str oai:diposit.ub.edu:2445/225042
network_acronym_str ES
network_name_str España
repository_id_str
spelling The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)Gracia Ahufinger, IreneLópez-González, LauraVasallo, FranciscoGalar, AliciaSiller, MaríaPitart, CristinaBloise, IvánTorrecillas, MiriamGijón Cordero, DesiréeViñado Pérez, BelenCastillo-García, JavierCampo, RainerMulet, XavierMadueño-Alonso, AnaChamizo-López, Francisco JavierArrastia-Erviti, MatianeGalán-Sánchez, FátimaFernández-Quejo, MelisaRodríguez-Díaz, Juan CarlosGutiérrez-Zufiaurre, María NievesRodríguez-Maresca, Manuel AngelOrtega-Lafont, María del PilarYagüe Guirao, GenovevaChaves-Blanco, LucíaColomina-Rodríguez, JavierVidal-Acuña, María ReyesPortillo, María EugeniaFranco-Álvarez de Luna, FranciscoCentelles-Serrano, María JoséAzcona-Gutiérrez, José ManuelDelgado-Iribarren García Campero, AlbertoRey-Cao, SoniaMuñoz, PatriciaCalvo Montes, JorgeZboromyrska, YuliyaGrandioso, DavidCàmara Mas, Jordi Cantón, RafaelLarrosa-Escartín, NievesDíaz Regañón, JazmínMartínez-Martínez, LuisBacteris gramnegatiusEscheríchia coliKlebsiella pneumoniaeGram-negative bacteriaEscherichia coliKlebsiella pneumoniaeIntroduction: Infections caused by carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa, including isolates producing acquired carbapenemases, constitute a prevalent health problem worldwide. The primary objective of this study was to determine the distribution of the different carbapenemases among carbapenemase-producing Enterobacterales (CPE, specifically Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae complex, and Klebsiella aerogenes) and carbapenemase-producing P. aeruginosa (CPPA) in Spain from January 2014 to December 2018. Methods: A national, retrospective, cross-sectional multicenter study was performed. The study included the first isolate per patient and year obtained from clinical samples and obtained for diagnosis of infection in hospitalized patients. A structured questionnaire was completed by the participating centers using the REDCap platform, and results were analyzed using IBM SPSS Statistics 29.0.0. Results: A total of 2,704 carbapenemase-producing microorganisms were included, for which the type of carbapenemase was determined in 2692 cases: 2280 CPE (84.7%) and 412 CPPA (15.3%), most often using molecular methods and immunochromatographic assays. Globally, the most frequent types of carbapenemase in Enterobacterales and P. aeruginosa were OXA-48-like, alone or in combination with other enzymes (1,523 cases, 66.8%) and VIM (365 cases, 88.6%), respectively. Among Enterobacterales, carbapenemase-producing K. pneumoniae was reported in 1821 cases (79.9%), followed by E. cloacae complex in 334 cases (14.6%). In Enterobacterales, KPC is mainly present in the South and South-East regions of Spain and OXA-48-like in the rest of the country. Regarding P. aeruginosa, VIM is widely distributed all over the country. Globally, an increasing percentage of OXA-48-like enzymes was observed from 2014 to 2017. KPC enzymes were more frequent in 2017-2018 compared to 2014-2016. Discussion: Data from this study help to understand the situation and evolution of the main species of CPE and CPPA in Spain, with practical implications for control and optimal treatment of infections caused by these multi-drug resistant organisms.Frontiers Media2023info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/225042Articles publicats en revistes (Fonaments Clínics)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.3389/fmicb.2023.1247804Frontiers in Microbiology, 2023, vol. 14https://doi.org/10.3389/fmicb.2023.1247804cc-by (c) Gracia-Ahufinger, I. et al., 2023http://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/2250422026-05-27T06:46:51Z
dc.title.none.fl_str_mv The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
title The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
spellingShingle The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
Gracia Ahufinger, Irene
Bacteris gramnegatius
Escheríchia coli
Klebsiella pneumoniae
Gram-negative bacteria
Escherichia coli
Klebsiella pneumoniae
title_short The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
title_full The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
title_fullStr The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
title_full_unstemmed The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
title_sort The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
dc.creator.none.fl_str_mv Gracia Ahufinger, Irene
López-González, Laura
Vasallo, Francisco
Galar, Alicia
Siller, María
Pitart, Cristina
Bloise, Iván
Torrecillas, Miriam
Gijón Cordero, Desirée
Viñado Pérez, Belen
Castillo-García, Javier
Campo, Rainer
Mulet, Xavier
Madueño-Alonso, Ana
Chamizo-López, Francisco Javier
Arrastia-Erviti, Matiane
Galán-Sánchez, Fátima
Fernández-Quejo, Melisa
Rodríguez-Díaz, Juan Carlos
Gutiérrez-Zufiaurre, María Nieves
Rodríguez-Maresca, Manuel Angel
Ortega-Lafont, María del Pilar
Yagüe Guirao, Genoveva
Chaves-Blanco, Lucía
Colomina-Rodríguez, Javier
Vidal-Acuña, María Reyes
Portillo, María Eugenia
Franco-Álvarez de Luna, Francisco
Centelles-Serrano, María José
Azcona-Gutiérrez, José Manuel
Delgado-Iribarren García Campero, Alberto
Rey-Cao, Sonia
Muñoz, Patricia
Calvo Montes, Jorge
Zboromyrska, Yuliya
Grandioso, David
Càmara Mas, Jordi
Cantón, Rafael
Larrosa-Escartín, Nieves
Díaz Regañón, Jazmín
Martínez-Martínez, Luis
author Gracia Ahufinger, Irene
author_facet Gracia Ahufinger, Irene
López-González, Laura
Vasallo, Francisco
Galar, Alicia
Siller, María
Pitart, Cristina
Bloise, Iván
Torrecillas, Miriam
Gijón Cordero, Desirée
Viñado Pérez, Belen
Castillo-García, Javier
Campo, Rainer
Mulet, Xavier
Madueño-Alonso, Ana
Chamizo-López, Francisco Javier
Arrastia-Erviti, Matiane
Galán-Sánchez, Fátima
Fernández-Quejo, Melisa
Rodríguez-Díaz, Juan Carlos
Gutiérrez-Zufiaurre, María Nieves
Rodríguez-Maresca, Manuel Angel
Ortega-Lafont, María del Pilar
Yagüe Guirao, Genoveva
Chaves-Blanco, Lucía
Colomina-Rodríguez, Javier
Vidal-Acuña, María Reyes
Portillo, María Eugenia
Franco-Álvarez de Luna, Francisco
Centelles-Serrano, María José
Azcona-Gutiérrez, José Manuel
Delgado-Iribarren García Campero, Alberto
Rey-Cao, Sonia
Muñoz, Patricia
Calvo Montes, Jorge
Zboromyrska, Yuliya
Grandioso, David
Càmara Mas, Jordi
Cantón, Rafael
Larrosa-Escartín, Nieves
Díaz Regañón, Jazmín
Martínez-Martínez, Luis
author_role author
author2 López-González, Laura
Vasallo, Francisco
Galar, Alicia
Siller, María
Pitart, Cristina
Bloise, Iván
Torrecillas, Miriam
Gijón Cordero, Desirée
Viñado Pérez, Belen
Castillo-García, Javier
Campo, Rainer
Mulet, Xavier
Madueño-Alonso, Ana
Chamizo-López, Francisco Javier
Arrastia-Erviti, Matiane
Galán-Sánchez, Fátima
Fernández-Quejo, Melisa
Rodríguez-Díaz, Juan Carlos
Gutiérrez-Zufiaurre, María Nieves
Rodríguez-Maresca, Manuel Angel
Ortega-Lafont, María del Pilar
Yagüe Guirao, Genoveva
Chaves-Blanco, Lucía
Colomina-Rodríguez, Javier
Vidal-Acuña, María Reyes
Portillo, María Eugenia
Franco-Álvarez de Luna, Francisco
Centelles-Serrano, María José
Azcona-Gutiérrez, José Manuel
Delgado-Iribarren García Campero, Alberto
Rey-Cao, Sonia
Muñoz, Patricia
Calvo Montes, Jorge
Zboromyrska, Yuliya
Grandioso, David
Càmara Mas, Jordi
Cantón, Rafael
Larrosa-Escartín, Nieves
Díaz Regañón, Jazmín
Martínez-Martínez, Luis
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Bacteris gramnegatius
Escheríchia coli
Klebsiella pneumoniae
Gram-negative bacteria
Escherichia coli
Klebsiella pneumoniae
topic Bacteris gramnegatius
Escheríchia coli
Klebsiella pneumoniae
Gram-negative bacteria
Escherichia coli
Klebsiella pneumoniae
description Introduction: Infections caused by carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa, including isolates producing acquired carbapenemases, constitute a prevalent health problem worldwide. The primary objective of this study was to determine the distribution of the different carbapenemases among carbapenemase-producing Enterobacterales (CPE, specifically Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae complex, and Klebsiella aerogenes) and carbapenemase-producing P. aeruginosa (CPPA) in Spain from January 2014 to December 2018. Methods: A national, retrospective, cross-sectional multicenter study was performed. The study included the first isolate per patient and year obtained from clinical samples and obtained for diagnosis of infection in hospitalized patients. A structured questionnaire was completed by the participating centers using the REDCap platform, and results were analyzed using IBM SPSS Statistics 29.0.0. Results: A total of 2,704 carbapenemase-producing microorganisms were included, for which the type of carbapenemase was determined in 2692 cases: 2280 CPE (84.7%) and 412 CPPA (15.3%), most often using molecular methods and immunochromatographic assays. Globally, the most frequent types of carbapenemase in Enterobacterales and P. aeruginosa were OXA-48-like, alone or in combination with other enzymes (1,523 cases, 66.8%) and VIM (365 cases, 88.6%), respectively. Among Enterobacterales, carbapenemase-producing K. pneumoniae was reported in 1821 cases (79.9%), followed by E. cloacae complex in 334 cases (14.6%). In Enterobacterales, KPC is mainly present in the South and South-East regions of Spain and OXA-48-like in the rest of the country. Regarding P. aeruginosa, VIM is widely distributed all over the country. Globally, an increasing percentage of OXA-48-like enzymes was observed from 2014 to 2017. KPC enzymes were more frequent in 2017-2018 compared to 2014-2016. Discussion: Data from this study help to understand the situation and evolution of the main species of CPE and CPPA in Spain, with practical implications for control and optimal treatment of infections caused by these multi-drug resistant organisms.
publishDate 2023
dc.date.none.fl_str_mv 2023
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/225042
url https://hdl.handle.net/2445/225042
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.3389/fmicb.2023.1247804
Frontiers in Microbiology, 2023, vol. 14
https://doi.org/10.3389/fmicb.2023.1247804
dc.rights.none.fl_str_mv cc-by (c) Gracia-Ahufinger, I. et al., 2023
http://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Gracia-Ahufinger, I. et al., 2023
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Frontiers Media
publisher.none.fl_str_mv Frontiers Media
dc.source.none.fl_str_mv Articles publicats en revistes (Fonaments Clínics)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869417782793207808
score 15.811543